Filing Details

Accession Number:
0001213900-24-016923
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-26 16:06:04
Reporting Period:
2024-01-29
Accepted Time:
2024-02-26 16:06:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1563577 Galera Therapeutics Inc. GRTX Pharmaceutical Preparations (2834) 461454898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2008233 Yair Schneid 1 Wood Lane
Suffern NY 10901
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-01-29 150,000 $0.18 7,260,801 No 4 P Direct
Common Stock Acquisiton 2024-01-30 335,000 $0.18 7,595,801 No 4 P Direct
Common Stock Acquisiton 2024-02-05 97,402 $0.18 7,693,203 No 4 P Direct
Common Stock Acquisiton 2024-02-06 25,000 $0.20 7,718,203 No 4 P Direct
Common Stock Acquisiton 2024-02-07 25,000 $0.17 7,743,203 No 4 P Direct
Common Stock Acquisiton 2024-02-07 150,000 $0.17 7,893,203 No 4 P Direct
Common Stock Acquisiton 2024-02-08 150,000 $0.17 8,043,203 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct